Convatec appoints Citigroup Global Markets Limited as joint corporate broker

Convatec Group Plc (LON:CTEC), a global medical products and technologies company, has announced the appointment of Citigroup Global Markets Limited as joint corporate broker, to work alongside its existing broker UBS Investment Bank, with immediate effect.

Convatec Group is a medical products and technologies company based in Reading, Berkshire, England. offering products and services in the areas of wound and skin care, ostomy care, continence and critical care and infusion devices.

Share on:

You might also enjoy reading Convatec Group Plc launches $300m share buyback programme

Written by: Amilia Stone

Latest Company News

Convatec Group Plc launches $300m share buyback programme

August 20, 2025

Convatec has announced a non-discretionary share buyback of up to $300 million to return surplus capital to shareholders. The programme, managed by UBS AG London Branch, will run until 31 December 2025 and aims to reduce the company’s share capital, with purchased shares either cancelled or held in treasury for employee plans.

Convatec Group welcomes CMS delay, ups FY25 InnovaMatrix® forecast

April 14, 2025

Convatec Group Plc celebrates the CMS's postponement of LCDs for diabetic foot ulcers, ensuring continued access to their trusted InnovaMatrix® for Medicare patients.

Convatec Group Plc reports broad-based, sustainable and profitable growth

February 26, 2025

Convatec Group Plc reports robust FY24 results with double-digit growth in EPS and cash flow, driven by strategic execution and expanded product offerings.